First International Ring Trial Demonstrates Capability of Laboratories to Measure CBD and Other Cannabinoids
This ring trial supports work underway to introduce an acceptable trace level of controlled cannabinoid content in consumer CBD products, to protect legitimate businesses and consumers from fraudulent or unsafe products.
Laughing Gas Relieves Symptoms of Treatment-Resistant Depression, New Study Finds
Results from a new clinical trial indicate that inhaling a mixture of 25 percent nitrous oxide and oxygen can provide long-lasting relief to those who have found other antidepressants ineffective.
Two-thirds of Delta-8 THC Products Do Not Contain Advertised Amount of Delta-8 THC, Report Finds
The report also found that over 50 percent of delta-8 THC products appear to contain more than the legally allowable limit of delta-9 THC.
Process By Which Ketamine Acts as an Antidepressant Confirmed
Ketamine can provide rapid antidepressant relief in as little as two hours that can be sustained for days to weeks.
Connecticut Legalizes Recreational Cannabis
After weeks of anticipation, the governor of Connecticut has signed the state’s recreational cannabis legalization bill, effectively legalizing marijuana from July 1.
The ACI Opens Belgian Office to Offer CBD Services to Europe
The cannabinoid trade group hopes the new venture will help expand its services into the European Union.
Louisiana Decriminalizes Cannabis Possession
While possession of 14 grams of cannabis (half an ounce) or less will remain punishable (with a maximum penalty of a $100 fine), the threat of prison time has been removed.
UK Government Advised to Move Regulation of Cannabinoids from Home Office to the Department of Health
Instead, according to a new report, the licensing system should be run by the UK’s Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency (MHRA).
More Than One-Third of Americans Support Psychedelics Legalization, New Poll Finds
The survey also found that 75 percent of respondents now support cannabis legalization for all purposes, with just 5 percent opposed to both recreational and medical legalization.
